Adaptive designs for IVPT data with mixed scaled average bioequivalence
Pharmaceutical Statistics · 2023
DOI: 10.1002/pst.2333 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmaceutical Statistics, 2023. Verfasst von Daeyoung Lim und 5 weiteren Autor:innen. Beteiligte Einrichtung: University of Connecticut, Storrs, Connecticut, USA. Hauptthemen laut MEDLINE: Research Design, Drugs, Generic. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 17 Literaturangaben.
Abstract (Originalsprache)
In vitro permeation tests (IVPT) offer accurate and cost‐effective development pathways for locally acting drugs, such as topical dermatological products. For assessment of bioequivalence, the FDA draft guidance on generic acyclovir 5% cream introduces a new experimental design, namely the single‐dose, multiple‐replicate per treatment group design, as IVPT pivotal study design. We examine the statistical properties of its hypothesis testing method—namely the mixed scaled average bioequivalence (MSABE). Meanwhile, some adaptive design features in clinical trials can help researchers make a decision earlier with fewer subjects or boost power, saving resources, while controlling the impact on family‐wise error rate. Therefore, we incorporate MSABE in an adaptive design combining the group sequential design and sample size re‐estimation. Simulation studies are conducted to study the passing rates of the proposed methods—both within and outside the average bioequivalence limits. We further consider modifications to the adaptive designs applied for IVPT BE trials, such as Bonferroni's adjustment and conditional power function. Finally, a case study with real data demonstrates the advantages of such adaptive methods.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- University of Connecticut, Storrs, Connecticut, USA.
- Office of Biostatistics, Office of Translational Science, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.
ORCID-Profile: Daeyoung Lim
Zitieren
APA
Lim, D., Rantou, E., Kim, J., Choi, S., Choi, N. H., & Grosser, S. (2023). Adaptive designs for IVPT data with mixed scaled average bioequivalence. Pharmaceutical Statistics. https://doi.org/10.1002/pst.2333
Vancouver
Lim D, Rantou E, Kim J, Choi S, Choi NH, Grosser S. Adaptive designs for IVPT data with mixed scaled average bioequivalence. Pharmaceutical Statistics. 2023. doi:10.1002/pst.2333
BibTeX
@article{Lim2023,
author = {Lim, Daeyoung and Rantou, Elena and Kim, Jessica and Choi, Sungwoo and Choi, Nam Hee and Grosser, Stella},
title = {Adaptive designs for IVPT data with mixed scaled average bioequivalence},
journal = {Pharmaceutical Statistics},
year = {2023},
doi = {10.1002/pst.2333}
}
EUVIMED